DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Atiprimod is an investigational drug.
There have been 5 clinical trials for Atiprimod. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2006.
The most common disease conditions in clinical trials are Carcinoma, Neuroendocrine, Carcinoma, and Neoplasms. The leading clinical trial sponsors are Callisto Pharmaceuticals, M.D. Anderson Cancer Center, and [disabled in preview].
Recent Clinical Trials for Atiprimod
|Extension Study of the Safety and Efficacy of Atiprimod Treatment in Neuroendocrine Carcinoma||Callisto Pharmaceuticals||Phase 2|
|Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma||Callisto Pharmaceuticals||Phase 2|
|An Open-Label Study of the Safety and Efficacy of Atiprimod Treatment for Patients With Advanced Cancer||Callisto Pharmaceuticals||Phase 1/Phase 2|